Evidence map›Paper›PMID 30053986›Full record

ArticleThe lancet. Diabetes & endocrinology2018

Risk-benefit profile of intensive blood pressure treatment - Authors' reply.

Srinivasan Beddhu, Tom Greene, Robert Boucher, William C Cushman, Guo Wei, Alfred K Cheung, Paul K Whelton, Glenn M Chertow

Abstract readLetterComment
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Srinivasan BeddhuMedical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA; Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: srinivasan.beddhu@hsc.utah.edu.
Tom GreeneDivision of Biostatistics, University of Utah School of Medicine, Salt Lake City, UT, USA.
Robert BoucherDivision of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
William C CushmanVeterans Affairs Medical Center, Memphis, TN, USA.
Guo WeiDivision of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Alfred K CheungMedical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA; Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Paul K WheltonTulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Glenn M ChertowStanford University, Palo Alto, CA, USA.

Funding

SPRINT - Factors Affecting Atherosclerosis Study (FAST)R01DK091437 · NIDDK · UNIVERSITY OF UTAH · PI BEDDHU, SRINIVASAN · 2011 to 2014
$2.3M
Long-term metabolic effects of kidney events with intensive SBP controlR01DK118219 · NIDDK · UNIVERSITY OF UTAH · PI BEDDHU, SRINIVASAN, CHERTOW, GLENN MATTHEW · 2018 to 2021
$1.2M
Sit Less, Interact, Move More (SLIMM) intervention for sedentary behavior in CKDR21DK106574 · NIDDK · UNIVERSITY OF UTAH · PI BEDDHU, SRINIVASAN · 2016 to 2017
$416k
Influence of baseline DBP on the effects of BP lowering on clinical outcomes: A participant level meta-analysis of RCTsR21HL145494 · NHLBI · UNIVERSITY OF UTAH · PI BEDDHU, SRINIVASAN · 2019 to 2020
$229k
NHLBI NIH HHS R21 HL145494NIDDK NIH HHS R01 DK091437NIDDK NIH HHS R01 DK118219NIDDK NIH HHS R21 DK106574
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood PressureHypertensionHumansRisk Assessment

Identifiers

PMID30053986
PMCPMC7351464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.